ID   KCC1G_HUMAN             Reviewed;         476 AA.
AC   Q96NX5; Q86UH5; Q9Y3J7;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2005, sequence version 3.
DT   15-MAR-2017, entry version 146.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type 1G;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM kinase I gamma;
DE            Short=CaM kinase IG;
DE            Short=CaM-KI gamma;
DE            Short=CaMKI gamma;
DE            Short=CaMKIG;
DE   AltName: Full=CaMK-like CREB kinase III;
DE            Short=CLICK III;
GN   Name=CAMK1G; Synonyms=CLICK3, VWS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-329.
RX   PubMed=10645953;
RA   Schutte B.C., Bjork B.C., Coppage K.B., Malik M.I., Gregory S.G.,
RA   Scott D.J., Brentzell L.M., Watanabe Y., Dixon M.J., Murray J.C.;
RT   "A preliminary gene map for the Van der Woude syndrome critical region
RT   derived from 900 kb of genomic sequence at 1q32-q41.";
RL   Genome Res. 10:81-94(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=12637513; DOI=10.1074/jbc.M300578200;
RA   Takemoto-Kimura S., Terai H., Takamoto M., Ohmae S., Kikumura S.,
RA   Segi E., Arakawa Y., Furuyashiki T., Narumiya S., Bito H.;
RT   "Molecular cloning and characterization of CLICK-III/CaMKIgamma, a
RT   novel membrane-anchored neuronal Ca2+/calmodulin-dependent protein
RT   kinase (CaMK).";
RL   J. Biol. Chem. 278:18597-18605(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Rhodes S.;
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-259; ILE-329 AND THR-443.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase belonging to
CC       a proposed calcium-triggered signaling cascade. In vitro
CC       phosphorylates transcription factor CREB1 (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin is thought to result in a conformational change and
CC       leads to activation through phosphorylation by CAMKK1 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Golgi apparatus
CC       membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC       Cell membrane {ECO:0000250}; Peripheral membrane protein
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96NX5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96NX5-2; Sequence=VSP_012138;
CC   -!- TISSUE SPECIFICITY: Mainly expressed in brain with small amounts
CC       in skeletal muscles, kidney, spleen and liver. Strongly expressed
CC       in forebrain neocortex, striatum and limbic system.
CC       {ECO:0000269|PubMed:12637513}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin
CC       binding region and interacts in the inactive folded state with the
CC       catalytic domain as a pseudosubstrate. {ECO:0000250}.
CC   -!- PTM: May be prenylated on Cys-473. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB41259.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF428261; AAL28100.1; -; mRNA.
DR   EMBL; AY212935; AAP29964.1; -; mRNA.
DR   EMBL; AL049688; CAB41259.1; ALT_INIT; mRNA.
DR   EMBL; AL023754; CAI19991.1; -; Genomic_DNA.
DR   EMBL; BC032787; AAH32787.1; -; mRNA.
DR   CCDS; CCDS1486.1; -. [Q96NX5-1]
DR   RefSeq; NP_065172.1; NM_020439.2. [Q96NX5-1]
DR   RefSeq; XP_016857355.1; XM_017001866.1. [Q96NX5-1]
DR   UniGene; Hs.199068; -.
DR   PDB; 2JAM; X-ray; 1.70 A; A/B=18-316.
DR   PDBsum; 2JAM; -.
DR   ProteinModelPortal; Q96NX5; -.
DR   SMR; Q96NX5; -.
DR   BioGrid; 121424; 6.
DR   IntAct; Q96NX5; 2.
DR   STRING; 9606.ENSP00000009105; -.
DR   BindingDB; Q96NX5; -.
DR   ChEMBL; CHEMBL5258; -.
DR   GuidetoPHARMACOLOGY; 1954; -.
DR   iPTMnet; Q96NX5; -.
DR   PhosphoSitePlus; Q96NX5; -.
DR   BioMuta; CAMK1G; -.
DR   DMDM; 73620970; -.
DR   PaxDb; Q96NX5; -.
DR   PeptideAtlas; Q96NX5; -.
DR   PRIDE; Q96NX5; -.
DR   DNASU; 57172; -.
DR   Ensembl; ENST00000009105; ENSP00000009105; ENSG00000008118. [Q96NX5-1]
DR   Ensembl; ENST00000361322; ENSP00000354861; ENSG00000008118. [Q96NX5-1]
DR   GeneID; 57172; -.
DR   KEGG; hsa:57172; -.
DR   UCSC; uc001hhd.4; human. [Q96NX5-1]
DR   CTD; 57172; -.
DR   DisGeNET; 57172; -.
DR   GeneCards; CAMK1G; -.
DR   HGNC; HGNC:14585; CAMK1G.
DR   MIM; 614994; gene.
DR   neXtProt; NX_Q96NX5; -.
DR   OpenTargets; ENSG00000008118; -.
DR   PharmGKB; PA26049; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; ENOG410XRMJ; LUCA.
DR   GeneTree; ENSGT00760000118944; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG108055; -.
DR   InParanoid; Q96NX5; -.
DR   KO; K08794; -.
DR   OMA; VGPCGCC; -.
DR   OrthoDB; EOG091G0HK9; -.
DR   PhylomeDB; Q96NX5; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   SignaLink; Q96NX5; -.
DR   SIGNOR; Q96NX5; -.
DR   EvolutionaryTrace; Q96NX5; -.
DR   GenomeRNAi; 57172; -.
DR   PRO; PR:Q96NX5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000008118; -.
DR   CleanEx; HS_CAMK1G; -.
DR   ExpressionAtlas; Q96NX5; baseline and differential.
DR   Genevisible; Q96NX5; HS.
DR   GO; GO:0005954; C:calcium- and calmodulin-dependent protein kinase complex; IEA:Ensembl.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Alternative splicing; ATP-binding;
KW   Calmodulin-binding; Cell membrane; Complete proteome; Cytoplasm;
KW   Golgi apparatus; Kinase; Lipoprotein; Membrane; Nucleotide-binding;
KW   Polymorphism; Prenylation; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    476       Calcium/calmodulin-dependent protein
FT                                kinase type 1G.
FT                                /FTId=PRO_0000086084.
FT   DOMAIN       23    277       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      29     37       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      277    317       Autoinhibitory domain. {ECO:0000250}.
FT   REGION      297    318       Calmodulin-binding. {ECO:0000250}.
FT   ACT_SITE    143    143       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      52     52       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VAR_SEQ     448    476       NFKSEVMVPVKASGSSHCRAGQTGVCLIM -> YVFLAKDG
FT                                APAWV (in isoform 2).
FT                                {ECO:0000303|PubMed:12637513}.
FT                                /FTId=VSP_012138.
FT   VARIANT     259    259       E -> Q (in dbSNP:rs35561962).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040600.
FT   VARIANT     329    329       V -> I (in dbSNP:rs11119315).
FT                                {ECO:0000269|PubMed:10645953,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_020530.
FT   VARIANT     443    443       A -> T (in a breast infiltrating ductal
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040601.
FT   CONFLICT    427    427       S -> N (in Ref. 1; AAL28100).
FT                                {ECO:0000305}.
FT   HELIX        19     22       {ECO:0000244|PDB:2JAM}.
FT   STRAND       23     31       {ECO:0000244|PDB:2JAM}.
FT   STRAND       33     42       {ECO:0000244|PDB:2JAM}.
FT   TURN         43     45       {ECO:0000244|PDB:2JAM}.
FT   STRAND       48     55       {ECO:0000244|PDB:2JAM}.
FT   HELIX        64     74       {ECO:0000244|PDB:2JAM}.
FT   STRAND       83     88       {ECO:0000244|PDB:2JAM}.
FT   STRAND       90     97       {ECO:0000244|PDB:2JAM}.
FT   HELIX       105    112       {ECO:0000244|PDB:2JAM}.
FT   HELIX       117    136       {ECO:0000244|PDB:2JAM}.
FT   HELIX       146    148       {ECO:0000244|PDB:2JAM}.
FT   STRAND      150    155       {ECO:0000244|PDB:2JAM}.
FT   STRAND      160    162       {ECO:0000244|PDB:2JAM}.
FT   HELIX       177    180       {ECO:0000244|PDB:2JAM}.
FT   TURN        188    190       {ECO:0000244|PDB:2JAM}.
FT   STRAND      191    193       {ECO:0000244|PDB:2JAM}.
FT   HELIX       198    214       {ECO:0000244|PDB:2JAM}.
FT   TURN        218    221       {ECO:0000244|PDB:2JAM}.
FT   HELIX       224    233       {ECO:0000244|PDB:2JAM}.
FT   TURN        240    245       {ECO:0000244|PDB:2JAM}.
FT   HELIX       248    258       {ECO:0000244|PDB:2JAM}.
FT   TURN        262    264       {ECO:0000244|PDB:2JAM}.
FT   HELIX       268    272       {ECO:0000244|PDB:2JAM}.
FT   HELIX       275    278       {ECO:0000244|PDB:2JAM}.
FT   HELIX       288    298       {ECO:0000244|PDB:2JAM}.
SQ   SEQUENCE   476 AA;  53087 MW;  DD009D9CF2FE3CBE CRC64;
     MGRKEEDDCS SWKKQTTNIR KTFIFMEVLG SGAFSEVFLV KQRLTGKLFA LKCIKKSPAF
     RDSSLENEIA VLKKIKHENI VTLEDIYEST THYYLVMQLV SGGELFDRIL ERGVYTEKDA
     SLVIQQVLSA VKYLHENGIV HRDLKPENLL YLTPEENSKI MITDFGLSKM EQNGIMSTAC
     GTPGYVAPEV LAQKPYSKAV DCWSIGVITY ILLCGYPPFY EETESKLFEK IKEGYYEFES
     PFWDDISESA KDFICHLLEK DPNERYTCEK ALSHPWIDGN TALHRDIYPS VSLQIQKNFA
     KSKWRQAFNA AAVVHHMRKL HMNLHSPGVR PEVENRPPET QASETSRPSS PEITITEAPV
     LDHSVALPAL TQLPCQHGRR PTAPGGRSLN CLVNGSLHIS SSLVPMHQGS LAAGPCGCCS
     SCLNIGSKGK SSYCSEPTLL KKANKKQNFK SEVMVPVKAS GSSHCRAGQT GVCLIM
//
